Nature Reviews Clinical Oncology is a monthly peer-reviewed academic journal published by Nature Portfolio. The journal was renamed from Nature Clinical Practice Oncology in April 2009. Nature Reviews Clinical Oncology is one of eight Clinical Review journals published by Nature Portfolio. It covers research developments and clinical practice in oncology. The editor-in-chief is Diana Romero.
The British Journal of Cancer is a twice-monthly professional medical journal owned by Cancer Research UK, published on their behalf by Springer Nature's Nature Research.
Nature Medicine is a monthly peer-reviewed medical journal published by Nature Portfolio covering all aspects of medicine. It was established in 1995. The journal seeks to publish research papers that "demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results". As with other Nature journals, there is no external editorial board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. The editor-in-chief is João Monteiro.
Infection and Immunity is a peer-reviewed medical journal published by the American Society for Microbiology. It focuses on interactions between bacterial, fungal, or parasitic pathogens and their hosts. Areas covered include molecular pathogenesis, cellular microbiology, bacterial infection, host responses and inflammation, fungal and parasitic infections, microbial immunity and vaccines, and molecular genomics. The journal publishes primary research articles, editorials, commentaries, minireviews, and a spotlight report highlighting articles of particular interest selected by the editors. Articles are freely accessible after 6 months. Through its "Global Outreach Program," free online access is available to qualified microbiologists in eligible developing countries.
Humana Press was an American academic publisher of science, technology, and medical books and journals founded in 1976. It was bought by Springer Science+Business Media in 2006.
The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the Lippincott Williams & Wilkins. It covers research on all aspects of clinical oncology. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 45.3 as reported by Clarivate in its 2022 Journal Citation Reports.
The International Journal of Molecular Sciences is a peer-reviewed open access scientific journal covering research in chemistry, molecular physics, and molecular biology. It is published by MDPI and was established in 2000. The editor-in-chief is Maurizio Battino.
Allied Academies is a reportedly fraudulent corporation chartered under the laws of North Carolina. Its postal address is in London, United Kingdom. It presents itself as an association of scholars, with supporting and encouraging research and the sharing and exchange of knowledge as its stated aims. The organization consists of 30 affiliate academies, which provide awards to academics and publish academic journals both online and in hard copy for members. Since 2015 the organization has been listed on Jeffrey Beall's list of "potential, possible, or probable predatory scholarly open-access publishers". It is in a partnership with OMICS Publishing Group which uses its website and logo. In 2018, OMICS owner Srinubabu Gedela declared that he had informed the Nevada court that Allied Academies was a subsidiary of OMICS International. During a conference in 2018, they falsely listed a prominent chemist among its organizing committee who had not agreed to this and was not affiliated with Allied Academies.
Oncogene is a peer-reviewed scientific journal published under the Nature Portfolio addressing cancer cell genetics and the structure and function of oncogenes. The journal has editorial office in London, England under the publishing company Springer Nature. The journal was established in 1987. An open access online-only sister journal, Oncogenesis, was established in 2012 by Douglas R. Green, who was then Oncogene's editor-in-chief.
Clinical Cancer Research is a peer-reviewed medical journal on oncology, including the cellular and molecular characterization, prevention, diagnosis, and therapy of human cancer, medical and hematological oncology, radiation therapy, pediatric oncology, pathology, surgical oncology, and clinical genetics. The applications of the disciplines of pharmacology, immunology, cell biology, and molecular genetics to intervention in human cancer are also included. One of the main interests of Clinical Cancer Research is on clinical trials that evaluate new treatments together with research on pharmacology and molecular alterations or biomarkers that predict response or resistance to treatment. Another priority for Clinical Cancer Research is laboratory and animal studies of new drugs as well as molecule-targeted agents with the potential to lead to clinical trials, and studies of targetable mechanisms of oncogenesis, progression of the malignant phenotype, and metastatic disease. The journal is published by the American Association for Cancer Research.
Cancer Epidemiology, Biomarkers & Prevention is a peer-reviewed medical journal devoted to research in the field of cancer epidemiology. Topics include descriptive, analytical, biochemical, and molecular epidemiology, the use of biomarkers to study the neoplastic and preneoplastic processes in humans, chemoprevention and other types of prevention trials, and the role of behavioral factors in cancer etiology and prevention. It is published by the American Association for Cancer Research and co-sponsored by the American Society of Preventive Oncology.
Human Reproduction is a peer-reviewed scientific journal covering all aspects of human reproduction, including reproductive physiology and pathology, endocrinology, andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, pregnancy, genetics, preimplantation genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics, and social issues. It is an official journal of the European Society of Human Reproduction and Embryology. It was established in 1986 with Robert Edwards as founding editor-in-chief.
Current Cancer Drug Targets is a peer-reviewed medical journal published by Bentham Science Publishers. The editor-in-chief is Ruiwen Zhang. The journal covers research on contemporary molecular drug targets involved in cancer, including medicinal chemistry, pharmacology, molecular biology, genomics, and biochemistry. Current Cancer Drug Targets publishes original research reports, review papers, and rapid communications ("letters").
Frontiers Media SA is a publisher of peer-reviewed, open access, scientific journals currently active in science, technology, and medicine. It was founded in 2007 by Kamila and Henry Markram. Frontiers is based in Lausanne, Switzerland, with other offices in London, Madrid, Seattle and Brussels. In 2022, Frontiers employed more than 1,400 people, across 14 countries. All Frontiers journals are published under a Creative Commons Attribution License.
Demetrios A. Spandidos is a Greek virologist and cancer researcher. He is an emeritus professor at the University of Crete where he was professor of virology from 1989 till 2015. He is also the founder of Spandidos Publications and the editor-in-chief of all eight of its journals.
The Journal of Cancer Research and Clinical Oncology is a monthly peer-reviewed medical journal covering oncology. It was established in 1903 under the name Zeitschrift für Krebsforschung, and changed its name to Zeitschrift für Krebsforschung und klinische Onkologie in 1971. The journal obtained its current name in 1979. It is published by Springer Science+Business Media under a hybrid publishing model and the editor-in-chief is Klaus Hoffken.
FEBS Open Bio is a monthly peer-reviewed open access scientific journal covering research and education in molecular and cellular life sciences. It was established in 2011 and is published by John Wiley & Sons on behalf of the Federation of European Biochemical Societies (FEBS). According to the journal, papers are not to be excluded on the basis of lack of perceived importance.
Molecular Cancer is a peer-reviewed open-access scientific journal covering all aspects of cancer research.
